Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  514 نتائج ل ""Amyloid beta-Peptides""

فلترة النتائج

Publisher : biomed central ltd
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Brain derived β-interferon is a potential player in Alzheimer's disease pathogenesis and cognitive impairment.

  • Authors : Wang Q; Department of Neurology and Institute on Aging and Brain Disorders, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Lujiang Road 17, Hefei, 230001, China. .; Neurodegenerative Disorder Research Center, Division of Life Sciences and Medicine, University of Science and Technology of China, Huangshan Road 443, Hefei, 230027, China. .

Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/cerebrospinal fluid ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/blood ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/diagnostic imaging

  • Source: Alzheimer's research & therapy [Alzheimers Res Ther] 2024 Dec 21; Vol. 16 (1), pp. 271. Date of Electronic Publication: 2024 Dec 21.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101511643 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Can the clinical sign "head-turning sign" and simple questions in "Neucop-Q" predict amyloid β pathology?

  • Authors : Daté Y; Department of Strokology and Neurology, Saiseikai Yokohamashi-Tobu Hospital, 3-6-1 Shimosueyoshi, Tsurumi-ku, Yokohama City, 230-8765, Japan.; Bun S

Subjects: Amyloid beta-Peptides*/Amyloid beta-Peptides*/Amyloid beta-Peptides*/metabolism ; Amyloid beta-Peptides*/Amyloid beta-Peptides*/Amyloid beta-Peptides*/blood ; tau Proteins*/tau Proteins*/tau Proteins*/blood

  • Source: Alzheimer's research & therapy [Alzheimers Res Ther] 2024 Nov 21; Vol. 16 (1), pp. 250. Date of Electronic Publication: 2024 Nov 21.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101511643 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Data-driven CSF biomarker profiling: imaging and clinical outcomes in a cohort at risk of Alzheimer's disease.

  • Authors : Argiris G; Department of Neuroscience, Columbia University, New York, NY, USA.; Akinci M

Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/cerebrospinal fluid ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/diagnostic imaging ; Biomarkers*/Biomarkers*/Biomarkers*/cerebrospinal fluid

  • Source: Alzheimer's research & therapy [Alzheimers Res Ther] 2024 Dec 23; Vol. 16 (1), pp. 274. Date of Electronic Publication: 2024 Dec 23.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101511643 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Elevated plasma p-tau231 is associated with reduced generalization and medial temporal lobe dynamic network flexibility among healthy older African Americans.

  • Authors : Budak M; Center for Molecular & Behavioral Neuroscience, Rutgers University-Newark, 197 University Avenue, Suite 209, Newark, NJ, 07102, USA. .; Fausto BA

Subjects: Amyloid beta-Peptides*/Amyloid beta-Peptides*/Amyloid beta-Peptides*/blood ; Biomarkers*/Biomarkers*/Biomarkers*/blood ; Black or African American*

  • Source: Alzheimer's research & therapy [Alzheimers Res Ther] 2024 Nov 22; Vol. 16 (1), pp. 253. Date of Electronic Publication: 2024 Nov 22.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101511643 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Gene-variant specific effects of plasma amyloid-β levels in Swedish autosomal dominant Alzheimer disease.

  • Authors : Johansson C; Department NVS, Division of Neurogeriatrics, Center for Alzheimer Research, Karolinska Institutet, Visionsgatan 4, Bioclinicum, Solna, J10:20, 171 64, Sweden.; Theme Inflammation and Aging, Karolinska University Hospital, Stockholm, Sweden.

Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/blood ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/genetics ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/cerebrospinal fluid

  • Source: Alzheimer's research & therapy [Alzheimers Res Ther] 2024 Sep 25; Vol. 16 (1), pp. 207. Date of Electronic Publication: 2024 Sep 25.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101511643 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Neurodegenerative biomarkers in different chambers of the eye relative to plasma: an agreement validation study.

  • Authors : Sampani K; Beetham Eye Institute, Joslin Diabetes Center, Boston, MA, 02115, USA.; Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA.

Subjects: Biomarkers*/Biomarkers*/Biomarkers*/blood ; tau Proteins*/tau Proteins*/tau Proteins*/blood ; tau Proteins*/tau Proteins*/tau Proteins*/cerebrospinal fluid

  • Source: Alzheimer's research & therapy [Alzheimers Res Ther] 2024 Aug 26; Vol. 16 (1), pp. 192. Date of Electronic Publication: 2024 Aug 26.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101511643 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Performance of plasma p-tau217 for the detection of amyloid-β positivity in a memory clinic cohort using an electrochemiluminescence immunoassay.

  • Authors : Dyer AH; Department of Age-Related Healthcare, Tallaght University Hospital, Dublin, Ireland. .; Discipline of Medical Gerontology, School of Medicine, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland. .

Subjects: tau Proteins*/tau Proteins*/tau Proteins*/blood ; tau Proteins*/tau Proteins*/tau Proteins*/cerebrospinal fluid ; Amyloid beta-Peptides*/Amyloid beta-Peptides*/Amyloid beta-Peptides*/blood

  • Source: Alzheimer's research & therapy [Alzheimers Res Ther] 2024 Aug 19; Vol. 16 (1), pp. 186. Date of Electronic Publication: 2024 Aug 19.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101511643 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Association of modifiable risk factors with progression to dementia in relation to amyloid and tau pathology.

  • Authors : Huszár Z; Centre for Translational Medicine, Semmelweis University, Üllői Út 26, Budapest, Hungary.; Department of Psychiatry and Psychotherapy, Semmelweis University, Balassa U. 6, Budapest, 1083, Hungary.

Subjects: Disease Progression* ; tau Proteins*/tau Proteins*/tau Proteins*/metabolism ; tau Proteins*/tau Proteins*/tau Proteins*/cerebrospinal fluid

  • Source: Alzheimer's research & therapy [Alzheimers Res Ther] 2024 Oct 26; Vol. 16 (1), pp. 238. Date of Electronic Publication: 2024 Oct 26.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101511643 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Amyloid deposition and its association with depressive symptoms and cognitive functions in late-life depression: a longitudinal study using amyloid-β PET images and neuropsychological measurements.

  • Authors : Kim K; Workplace Mental Health Institute, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea.; Jang YJ

Subjects: Positron-Emission Tomography*/Positron-Emission Tomography*/Positron-Emission Tomography*/methods ; Amyloid beta-Peptides*/Amyloid beta-Peptides*/Amyloid beta-Peptides*/metabolism ; Neuropsychological Tests*

  • Source: Alzheimer's research & therapy [Alzheimers Res Ther] 2024 Oct 19; Vol. 16 (1), pp. 232. Date of Electronic Publication: 2024 Oct 19.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101511643 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Elevated Aβ aggregates in feces from Alzheimer's disease patients: a proof-of-concept study.

  • Authors : Pils M; Institute of Biological Information Processing, Structural Biochemistry (IBI-7), Forschungszentrum Jülich, 52428, Jülich, Germany.; attyloid GmbH, 40225, Düsseldorf, Germany.

Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/metabolism ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/pathology ; Feces*/Feces*/Feces*/chemistry

  • Source: Alzheimer's research & therapy [Alzheimers Res Ther] 2024 Oct 14; Vol. 16 (1), pp. 223. Date of Electronic Publication: 2024 Oct 14.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101511643 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  514 نتائج ل ""Amyloid beta-Peptides""